Home > Insider Trading > Filing (0001209191-20-038471)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
831547	Spectrum Pharmaceuticals Inc	SPPI	Pharmaceutical Preparations (2834)	930979187

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1474553	William Ashton	11500 S. Eastern Ave., Suite 240 Henderson NV 89052		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Disposition	2020-06-22	5,000	$3.25	41,666	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2020-06-18	60,000	$0.00	60,000	$2.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
60,000		2030-06-18	No	4	A	Direct

Footnotes

All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
This stock option grant was previously reported on a Form 4 on June 19, 2020. This is an amendment to that Form 4 to reflect an inadvertent error in Column 7 under the "Amount or Number of Shares".
One third of the aggregate amount of option shares shall vest on each of June 18, 2021, 2022 and 2023, respectively.